PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
18025279-0	2007	Glycosaminoglycans and their synthetic mimetics inhibit RANTES-induced migration and invasion of human hepatoma cells.	Glycosaminoglycans	0-18	C-C motif chemokine ligand 5	Homo sapiens	56-62	
18025279-1	2007	The CC-chemokine regulated on activation, normal T-cell expressed, and presumably secreted (RANTES)/CCL5 mediates its biological activities through activation of G protein-coupled receptors, CCR1, CCR3, or CCR5, and binds to glycosaminoglycans.	Glycosaminoglycans	225-243	C-C motif chemokine ligand 5	Homo sapiens	92-98	
18025279-1	2007	The CC-chemokine regulated on activation, normal T-cell expressed, and presumably secreted (RANTES)/CCL5 mediates its biological activities through activation of G protein-coupled receptors, CCR1, CCR3, or CCR5, and binds to glycosaminoglycans.	Glycosaminoglycans	225-243	C-C motif chemokine ligand 5	Homo sapiens	100-104	
18025279-4	2007	RANTES/CCL5 binding to these cells depends on CCR1 and glycosaminoglycans.	Glycosaminoglycans	55-73	C-C motif chemokine ligand 5	Homo sapiens	0-6	
18025279-4	2007	RANTES/CCL5 binding to these cells depends on CCR1 and glycosaminoglycans.	Glycosaminoglycans	55-73	C-C motif chemokine ligand 5	Homo sapiens	7-11	
18025279-7	2007	The fact that RANTES/CCL5-induced migration and invasion of Huh7 cells are both strongly inhibited by anti-CCR1 antibodies and heparin, as well as by beta-d-xyloside treatment of the cells, suggests that CCR1 and glycosaminoglycans are involved in these events.	Glycosaminoglycans	213-231	C-C motif chemokine ligand 5	Homo sapiens	14-20	
18025279-7	2007	The fact that RANTES/CCL5-induced migration and invasion of Huh7 cells are both strongly inhibited by anti-CCR1 antibodies and heparin, as well as by beta-d-xyloside treatment of the cells, suggests that CCR1 and glycosaminoglycans are involved in these events.	Glycosaminoglycans	213-231	C-C motif chemokine ligand 5	Homo sapiens	21-25	
18025279-8	2007	We then show by surface plasmon resonance that synthetic glycosaminoglycan mimetics, OTR4120 or OTR4131, directly bind to RANTES/CCL5.	Glycosaminoglycans	57-74	C-C motif chemokine ligand 5	Homo sapiens	122-128	
18025279-8	2007	We then show by surface plasmon resonance that synthetic glycosaminoglycan mimetics, OTR4120 or OTR4131, directly bind to RANTES/CCL5.	Glycosaminoglycans	57-74	C-C motif chemokine ligand 5	Homo sapiens	129-133	
18025279-10	2007	Therefore, targeting the RANTES-glycosaminoglycan interaction could be a new therapeutic approach for human hepatocellular carcinoma.	Glycosaminoglycans	32-49	C-C motif chemokine ligand 5	Homo sapiens	25-31